On Air Now

Listen

Listen Live Now » 101.1 FM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
36° Feels Like: 31°
Wind: E 6 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Mostly Sunny 50°

Tonight

Mostly Clear 30°

Tomorrow

Partly Cloudy 56°

Alerts

Bayer to partner on reversing bleeding from Xarelto

FRANKFURT (Reuters) - German drugmaker Bayer said on Tuesday it planned to collaborate with U.S. peer Portola Pharmaceuticals to study several drugs that reverse the effects of its blood-thinner Xarelto.

Bayer said it expected to complete the study in the second half of this year.

Dangerous bleeding is one of the main risks of bloodthinners such as Xarelto, which are used against thrombosis or heart attacks, and drugs can be applied more widely if they have so-called "antidotes".

U.S. regulators last June rejected the use of Xarelto to prevent heart attacks and strokes in patients with acute coronary syndrome (ACS), citing the risk of bleeding.

Bayer said in September its development partner Johnson & Johnson had filed a response to the regulators' concerns.

(Reporting By Peter Dinkloh; Editing by David Cowell)

Comments